EYPT
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when EyePoint, Inc. publishes a filing, an earnings call transcript or a press release.
Get EYPT alertsThe proxy statement of EyePoint, Inc. reports total compensation of $2,157,130 for Ramiro Ribeiro in fiscal 2025, including a base salary of $505,007. Disclosed compensation is on record for 3 fiscal years. Ramiro Ribeiro has spoken on 2 investor events across 1 company, most recently for EyePoint, Inc. on September 15, 2026. EyePoint, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at EyePoint, Inc. includes Jay Duker (CEO, COO and Board Member), Jay S. Duker (CEO and Board Member), Jay S. Duker, M.D. (CEO, COO and Board Member) and 7 others.
“So in terms of study design, Lugano and Lucia are identical, exactly the same type of study design. In terms of the patient population, the only difference is that Lugano was 100% U.S. patients and Lucia is 80% U.S., 20% international.”
“In ophthalmology, there are several precedents of submissions and drugs that got approved with one study being negative and then the other study being positive.”
Proxy statement
Start not stated–present
Last confirmed April 27, 2026
EYPT
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | EyePoint, Inc. (EYPT) | Chief Medical Officer | $505,007 | $2,157,130 |
| 2024 | EyePoint, Inc. (EYPT) | Chief Medical Officer | $404,167 | $3,533,919 |
| 2023 | EyePoint, Inc. (EYPT) | Chief Medical Officer | — | — |